Skip to main content

Quantum Biopharma Ltd Cls B Subordinate Voting S(QNTM-CN)
CSE

Today's Change
Delayed Last Update

Quantum Biopharma Ltd Cls B Subordinate Voting S

199 Bay Street
Suite 4000
Toronto ON M5L 1A9 CAN
P: 416-854-8884
https://www.fsdpharma.com

Profile

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

Key Executives

NameTitle
Donal CarrollCOO
Zeeshan SaeedCEO/Co-Chairman of the Board/Co-Founder/Director/President
Nathan CoyleCFO
Lakshmi P. KotraCEO, Subsidiary/Director